Obagi Medical Products, commonly referred to as Obagi, is a leading name in the skincare industry, headquartered in the United States. Founded in 1988, the company has established itself as a pioneer in developing innovative skincare solutions, particularly in the realm of prescription-strength products. Obagi's primary focus areas include anti-ageing, skin health, and pigmentation correction, catering to both professional and consumer markets. With a commitment to scientific research and dermatological expertise, Obagi offers a range of unique products, including the renowned Obagi Nu-Derm System, which is designed to transform skin at the cellular level. The brand's dedication to quality and efficacy has earned it a strong market position, making it a trusted choice among skincare professionals and consumers alike. Notable achievements include numerous awards for product innovation and a loyal customer base that spans across major operational regions worldwide.
How does Obagi's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Obagi's score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Obagi, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a merged entity of Obagi Cosmeceuticals LLC and inherits its climate commitments from its parent organisation, Waldencast plc. While there are no documented reduction targets or specific climate pledges available, the cascading of data from Waldencast plc suggests a commitment to sustainability within the corporate family. However, without explicit emissions data or reduction initiatives, it is challenging to assess Obagi's current climate impact or future commitments. As the industry increasingly prioritises climate action, it is essential for Obagi to establish clear emissions reporting and reduction strategies to align with global sustainability goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Obagi has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.